Vaughan Nelson Investment Management L.P. Acquires Shares of 1,839,125 Acadia Healthcare Company, Inc. $ACHC

Vaughan Nelson Investment Management L.P. bought a new position in Acadia Healthcare Company, Inc. (NASDAQ:ACHC) during the first quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor bought 1,839,125 shares of the company’s stock, valued at approximately $43,017,000.

A number of other institutional investors and hedge funds have also bought and sold shares of ACHC. EverSource Wealth Advisors LLC raised its holdings in Acadia Healthcare by 54.8% in the second quarter. EverSource Wealth Advisors LLC now owns 1,404 shares of the company’s stock worth $32,000 after buying an additional 497 shares during the last quarter. Federated Hermes Inc. grew its holdings in shares of Acadia Healthcare by 1.5% during the fourth quarter. Federated Hermes Inc. now owns 43,913 shares of the company’s stock valued at $623,000 after buying an additional 668 shares during the last quarter. Price T Rowe Associates Inc. MD increased its position in shares of Acadia Healthcare by 0.9% during the fourth quarter. Price T Rowe Associates Inc. MD now owns 74,907 shares of the company’s stock valued at $1,063,000 after acquiring an additional 696 shares in the last quarter. Public Employees Retirement System of Ohio increased its position in shares of Acadia Healthcare by 2.8% during the third quarter. Public Employees Retirement System of Ohio now owns 31,335 shares of the company’s stock valued at $776,000 after acquiring an additional 867 shares in the last quarter. Finally, Treasurer of the State of North Carolina raised its holdings in Acadia Healthcare by 2.1% in the 2nd quarter. Treasurer of the State of North Carolina now owns 42,502 shares of the company’s stock worth $964,000 after acquiring an additional 867 shares during the last quarter.

Wall Street Analysts Forecast Growth

Several analysts have commented on ACHC shares. Weiss Ratings reiterated a “sell (d)” rating on shares of Acadia Healthcare in a research note on Friday, June 12th. Leerink Partners boosted their price target on Acadia Healthcare from $14.00 to $22.00 and gave the stock a “market perform” rating in a research note on Thursday, February 26th. Royal Bank Of Canada upped their price target on Acadia Healthcare from $28.00 to $31.00 and gave the company an “outperform” rating in a report on Monday, May 4th. Zacks Research upgraded Acadia Healthcare from a “strong sell” rating to a “hold” rating in a report on Thursday, March 5th. Finally, UBS Group boosted their price objective on shares of Acadia Healthcare from $27.00 to $31.00 and gave the company a “buy” rating in a report on Friday, April 17th. One equities research analyst has rated the stock with a Strong Buy rating, seven have issued a Buy rating, five have given a Hold rating and two have given a Sell rating to the stock. According to data from MarketBeat, Acadia Healthcare has an average rating of “Hold” and a consensus price target of $26.85.

Acadia Healthcare Stock Performance

Shares of ACHC opened at $24.87 on Monday. The business has a 50-day simple moving average of $25.49 and a two-hundred day simple moving average of $20.34. The company has a quick ratio of 1.71, a current ratio of 1.71 and a debt-to-equity ratio of 1.27. Acadia Healthcare Company, Inc. has a 52 week low of $11.43 and a 52 week high of $30.20. The stock has a market cap of $2.29 billion, a price-to-earnings ratio of -2.03, a PEG ratio of 8.30 and a beta of 0.69.

Acadia Healthcare (NASDAQ:ACHC) last posted its quarterly earnings data on Wednesday, April 29th. The company reported $0.37 earnings per share for the quarter, beating analysts’ consensus estimates of $0.28 by $0.09. The firm had revenue of $828.80 million for the quarter, compared to analysts’ expectations of $823.51 million. Acadia Healthcare had a positive return on equity of 7.09% and a negative net margin of 32.84%.The business’s quarterly revenue was up 7.6% on a year-over-year basis. During the same period in the previous year, the firm earned $0.40 EPS. Acadia Healthcare has set its Q2 2026 guidance at 0.300-0.400 EPS. On average, analysts expect that Acadia Healthcare Company, Inc. will post 1.5 EPS for the current year.

About Acadia Healthcare

Acadia Healthcare Company, Inc (NASDAQ: ACHC) is a publicly traded provider of behavioral healthcare services headquartered in Franklin, Tennessee. Founded in 2005, the company has grown through organic expansion and strategic acquisitions to establish itself as a leading specialist in mental health and addiction treatment across the United States.

Acadia operates a diversified network of inpatient psychiatric hospitals, residential treatment centers, outpatient clinics and intensive outpatient programs.